Illumina (ILMN) Optics for Genomics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Illumina (ILMN) Optics for Genomics

ILMN 122.42

+4.7%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mopgcw who wrote (76)	1/4/2004 1:44:08 AM
From: mopgcw	of 276

Illumina to offer up to $65 mln in common stock Tuesday December 23, 2:43 pm ET WASHINGTON, Dec 23 (Reuters) - Health products maker Illumina Inc. (NasdaqNM:ILMN - News) filed with the U.S. Securities and Exchange Commission (News - Websites) on Tuesday to offer up to $65 million in common stock. Net proceeds from the sale will be used for general corporate purposes, which may include research and development, product development and debt repayment, the company said in a shelf registration statement. Such a filing is designed to give companies advance regulatory permission to sell securities in one or more offerings. Illumina shares traded 28 cents lower at $6.90 Tuesday afternoon on the Nasdaq stock market.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next